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ABSTRACT
Photon counting detectors are of growing importance in medical imaging because they enable routine measure-
ment of photon energy. Detectors such as Medipix2 and Medipix3 record the energy of incident photons with
minimal loss of spatial resolution. Their use is being investigated for both pre-clinical and clinical applications
of X-ray CT. The Medipix3 detector has 256 x 256 55 m pixels and a silicon or cadmium telluride detector
layer, giving a spatial resolution comparable to mammographic lm. Each Medipix pixel can be seen as an indi-
vidual spectral detector. The logic circuits for each pixel (some 1300 transistors) can analyze incoming events at
megahertz rates, comparing the charge of the electron-hole cloud with preset levels, giving a resolution of about
2 keV across the range of 8 - 140 keV.
A prototype CT scanner has been developed for laboratory animals and excised specimens. Applications under
investigation include: K-edge imaging: Using spectral information to measure heavy elements (e.g., preparations
of iodine, barium, and gadolinium) and Soft tissue contrast: Dual energy systems have shown that image contrast
for soft tissue can be improved, e.g., distinguishing between iron and calcium within vascular plaques.
1. INTRODUCTION
Spectroscopic x-ray detectors, such as Medipix,1,2 are opening the door to the widespread use of energy selective
biomedical x-ray imaging. With dual energy computed tomography rapidly establishing itself as the clinical
standard for many radiological investigations, spectroscopic imaging is a likely next step. However to conrm
the utility of spectroscopic x-ray detectors there needs to be a clearer indication of the clinical benets of the
technology.
Some 15 years ago the rst Medipix Collaboration was formed to transfer the ideas generated in designing
detectors to characterize the jets of particles created in 14GeV proton-on-proton collisions (for the CERN Large
Hadron Collider), to medical and industrial applications. The University of Canterbury is a foundation member
of the Medipix3 collaboration. The Medipix3 2D imaging detector2 has the ability to count photon events within
up to 8 separate energy bands and the ability to arbitrate between neighboring pixels to decide to which a
particular photon event belongs (charge summing mode). In single pixel mode, the detector resolution is 55 m.
In order to identify possible applications of spectroscopic imaging we conducted a literature review of clinical
applications of dual energy systems.3{7 In addition we analyzed simulation results from our own group, our
collaborating partners, and industry.8{13
We expect that the benets of spectroscopic x-ray imaging lie in three areas:
1. Improved image quality, in particular a reduction in beam hardening artefact and scatter reduction.14,15
2. K-edge imaging, i.e., the identication of high Z-number contrast agents based on their k-edge. Potential
advantages include a) less contrast agent required in high risk patients such as those with renal impairment,
diabetes, or the elderly, and b) separation of several contrast agents allowing for multi-phase studies to be
performed with a lower x-ray dose and less time on the scanner.13,16,17
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3. Improved soft tissue contrast from dierences in mass attenuation coecients of dierent tissues. The
diagnoses of several diseases, such as breast cancer, are known to be improved by dual energy systems. In
addition, there is improved soft tissue contrast of normal structures.12,18,19
These potential benets need to be weighed up with the clinical signicance of diseases and current radiological
practice. Our own eorts to evaluate the potential for spectral CT have included using principal components
analysis to separate regions of dierent attenuation characteristics,10 distinguishing dierent contrast agents
in an animal preparation,11,17 and distinguishing soft tissue types.12 In this paper we review the underlying
technology, the eorts taken to date at analyzing spectral CT outputs, and summarize two specic applications.
Two results are presented in support of our conclusions that spectral CT has a promising future.
2. MEDIPIX DETECTOR
The Medipix detector is a by-product of the Large Hadron Collider project at CERN. A small company was
established to design and build the detector and a large collaboration of universities and research institutes has
been formed to develop applications and accessories for the detector family. A number of studies have employed
the Medipix2.1 The current state of development is the Medipix3.
Both silicon (Si) and cadmium telluride (CdTe) detector layers have been tested on prototype Medipix sensors.
Substantially higher energy photons can be imaged with the CdTe detector, so it seems that the broader spectrum
that can thereby be exploited will make it the material of choice for the imaging of biological specimens.
2.1. Medipix3
The Medipix chip is 14 mm  14 mm and comprises 256  256 square pixels, each of edge length 55 m.2 The
Medipix3 prototype chip has been designed and manufactured in 0.13 m CMOS technology with eight metal
layers. This allows a high degree of interconnectivity between pixels and the implementation of more functionality
while maintaining a compact pixel area. New features on the Medipix3 compared to its predecessors include the
ability to arbitrate which pixel is assigned an x-ray photon which strikes the detector in between pixel centers
and the ability to distinguish 8 energies simultaneously with 110 m resolution.
3. MULTIPLE ENERGIES IN CT
We see the work of Alvarez & Macovski (1976),14 who used two energies to nd coecients for two basis
functions, as seminal in the eld of exploiting energy sensitive detectors. The basis functions proposed by
Alvarez & Macovski were each modeling one of the primary attenuation processes: photoelectric interactions
and Compton scattering. As well as establishing an elegant framework for analysing multi-energy systems, they
showed a simulated example that resolved fatty tissue in the brain, comparing a standard reconstruction and the
reconstructions of each of their two coecients. A number of other researchers have used Alvarez and Macovski's
basis functions in their work and in some cases extended the fundamental idea with additional functions.4,16,20
Roessl & Proksa (2007)16 were primarily interested in imaging of k-edge materials. This paper contains a
simulated scan where they need to distinguish between a gadolinium-based contrast agent and an atherosclerotic
plaque, where they claim that conventional integrating systems struggle or fail to dierentiate between the two
materials while their energy-selective system shows a strong contrast between them.
Schlomka et al21 concentrate on k-edge imaging. This paper is the experimental follow-up to Roessl &
Proksa.16 They have successfully managed to extend Alvarez and Macovski's14 two basis functions to four, and
identify iodine and gadolinium within a phantom containing both. Interestingly, their choice of four basis func-
tions were: photoelectric absorption, Compton scattering, attenuation by iodine, and attenuation by gadolinium.
The functions describing the latter two were designed to model the total attenuation caused by these elements.
The energy weighting technique for using spectral information has received a lot of attention. The original
work seems to have been that of Tapiovaara & Wagner (1985).22 A simple two-material model is adopted to
derive optimal weightings for each energy bin based on maximizing the SNR. Niederlohner et al8,23 report that
their simulations predict an SNR improvement of a factor up to 1.5 compared to a conventional integrating
detector.
Taguchi et al have recently studied the eects of pulse pileup, which is likely to occur if ux rates are high.24
3.1. Principal components analysis
Our own eorts at reconstructing CT images from multiple energy recordings have centered on the use of principal
components analysis (PCA).10 The goal of PCA is to identify linearly independent patterns of variance within
a data set. PCA can be applied to object projections, as it was in Butzer et al ,10 or to reconstructed 3D
data.17 With PCA, eigenimages can be formed for each of the largest eigenvalues and these correspond to strong
substance types in the data. Thus an implicit model for the energy dependence is built, based on the data,
rather than one based on a model.
4. APPLICATIONS
Biomedical applications for the Medipix-based CT scanner under investigation can broadly be grouped into
those that rely on radiographic pharmaceuticals with suitable k-edges and those based on the intrinsic contrast
of tissues.
4.1. K-edge imaging
Extrinsic radiological pharmaceuticals used for human, small animal, or pathology specimens commonly have
heavy elements. These elements have an photoelectric absorption edge that can be measured by looking at the
energy specic attenuation above and below the k-edge or l-edge.
For clinical imaging the choice of atom depends on the absorption edge being within a suitable x-ray energy
range, typically 30-120 keV, and the possibility of developing a tolerated pharmaceutical. For pre-clinical exper-
iments where the specimen or animal tends to be smaller and/or non-living these requirements can be relaxed,
allowing the use of a greater range of pharmaceutical products. In clinical practice the heavy atoms used include
iodine, gadolinium, and barium. In small animal imaging and specimen imaging the list is extended to include
gold, silver, lead, and many others.
Being able to identify and quantify pharmaceutical agents allows several contrast agents to be used in con-
junction.11,13,17 Combinations in dierent body spaces or dierent timing of infusions can then yield information
on complex anatomy or physiology. For example, one pharmaceutical could be infused into a vessel's lumen and
a dierent agent introduced into the vaso vasorum of the vessel wall.
Another application of k-edge imaging in pre-clinical investigations is atomic substitution. It has been known
for a long time that many light elements found in normal physiology can be substituted with heavier elements.25,26
Typically, substitution involves replacing a light element with a heavier element with a similar outer electron
conguration. Thus the heavier element has similar chemical properties but better x-ray attenuation properties.
Published examples include substituting strontium (k-edge 16 keV) for physiological calcium and rubidium (k-
edge 15 keV) for physiological potassium. In these substitutions the lighter elements have very low k-edges that
are not suitable for imaging while the heavier elements have k-edges in the range used for imaging small objects.
There are many groups in the world developing nano-particles and other functional pharmaceuticals. These
agents often contain gold or other heavy elements.27,28 Currently, our institute is developing simple gold con-
taining lipid spheres of consistent size to measure permeability of sinusoids within the liver.
4.2. Intrinsic contrast
Dierent tissues of the body have dierent energy-specic attenuation proles (linear attenuation coecients).
This has been exploited for dual energy CT and applications under investigation or of proven clinical utility
include renal stone characterization and bone removal.18{20 While improved intrinsic tissue contrast is very
promising, with the use of dual energy CT technology applications have been limited by noise and/or x-ray dose.
This is because the dual energy CT usually involves dual exposures with two overlapping source x-ray spectra.
A clinically very important example of the need for intrinsic tissue contrast is in dierentiating iron and
calcium within vascular atheroma plaques.29 The strong clinical need is to identify plaques which are likely to
rupture, causing stroke or heart attack. While this is a challenging application for energy resolved imaging, it is
tantalisingly close with dual energy CT. It is hoped that the improved energy information from spectral photon
counting CT systems may address this clinical need.
5. RESULTS
The results presented here are indicative only of the work performed to date. Please see Butzer et al (2008),10
Berg et al (2009),12 and Anderson et al (2010)17 for other examples from the group.
In Fig. 1 the measured response of a prototype Medipix3 sensor with a Si detector layer has been characterized
with respect to direct (\open" beam) exposure to a small x-ray source at 50 keV. A complete spectrum has been
obtained by making repeated measurements with dierent energy threshold settings for the Medipix3. The
dominant eect of charge sharing at low energies which is evident in Fig. 1(a) is virtually removed when the
charge summing mode (CSM) is invoked (Fig. 1(b)). The residual peak at low energies in Fig. 1(b) is largely
contributed by electronic noise.
(a) (b)
Figure 1. Response of a Medipix3 with Si detection layer. The Source Ray Inc. x-ray tube has intrinsic ltration of 1.8
mm Al (equivalent). (a) In the single pixel mode (SPM), charge sharing eects dominate at lower energies. (b) This eect
is remedied by the application of charge summing mode (CSM). The working range of this conguration of Medipix3 is
for E  15 - 50 keV (corresponding to DAC values  70 - 200).
In Fig. 2, the results of imaging with a Medipix2 sensor with a CdTe detector layer are shown. The object
imaged was a phantom comprising cylindrical holes in a perspex block, each lled will a dierent contrast
substance. The relative location of the cylinders is shown in Fig. 2(a). A set of repeated measurements with
dierent energy threshold settings for the Medipix2 were made. Then planar tomographic reconstructions were
made by ltered back projection and the images combined by PCA to identify regions with attenuation of diering
energy dependence. The resulting coloured image is shown in Fig. 2(b). There is a clear dierence shown between
the iodine, barium and gadolinium regions and each of these is dierent to the reference water-lled cylinder.
6. CONCLUSIONS
Spectral CT, using energy discriminating detectors like Medipix, seems a natural successor to dual-energy CT
in medical imaging. However, the increase in complexity involved must be motivated by proven clinical utility.
Evidence is accumulating that intrinsic tissue contrast may be improved with spectral CT. The high eciency
aorded by the charge summing feature of Medipix3 promises to allow dose reduction, while early results support
the conjecture that spectral CT will allow new diagnostic methods employing multiple contrast agents.
7. ACKNOWLEDGEMENTS
The authors wish to acknowledge the contributions and encouragement of the Medipix2 and Medipix3 Collabo-
rations (http://medipix.web.cern.ch/MEDIPIX/). We thank in particular Dr Michael Fiederle (Albert-Ludwigs-
Universitat Freiburg) for supplying the CdTe used in forming Fig. 2(b).
(a) (b)
Figure 2. An image formed by imaging with a CdTe detector layer. (a) The key to the cross-section of the phantom
which comprised a perspex block with 4 cylindrical holes, each lled with a dierent contrast medium. (b) A tomogram
formed by reconstructing from projections and using PCA to separate dierent absorption versus energy characteristics
of the contrast media. When the image is viewed in colour, the iodine appears red, the gadolinium green, the barium
blue/pink, and the water dark blue.
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